Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.62
-0.1600-1.48%
Post-market: 10.620.00000.00%19:30 EDT
Volume:126.31K
Turnover:1.35M
Market Cap:372.41M
PE:-88.50
High:10.88
Open:10.78
Low:10.59
Close:10.78
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.64
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.77
PE(LYR):-31.16

Loading ...

Fennec grants 50,000 stock options to new hires at $9.75 per share

Reuters
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 19

Fennec Pharma publishes corporate presentation on PEDMARK hearing loss prevention in cisplatin patients

Reuters
·
May 19

Wedbush Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 18

Piper Sandler Sticks to Its Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 15

Fennec Q1 FY26 swings to profit of $201,000; net sales rise 72.64% to $15.11 million

Reuters
·
May 15

Fennec Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Fennec Pharmaceuticals Q1 sales rise 73% on PEDMARK demand

Reuters
·
May 14

Fennec Pharmaceuticals Q1 Net Income USD 201 Thousand

THOMSON REUTERS
·
May 14

Fennec Pharmaceuticals Q1 Operating Expenses USD 15.227 Million

THOMSON REUTERS
·
May 14

Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Fennec Pharma director Chris Rallis disposes 8,346 common shares for $58,755.84

Reuters
·
May 13

Fennec Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 12

Fennec Pharmaceuticals Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 08

Fennec says four PEDMARK studies accepted for presentation at 2026 ASCO meeting

Reuters
·
May 07

Fennec Pharmaceuticals to report first-quarter 2026 results, hosts conference call and webcast

Reuters
·
May 07

Fennec Pharma director Rosty Raykov disposes of common shares worth $69,754.07

Reuters
·
May 02

Fennec Pharma director Rostislav Raykov to retire, not seek re-election

Reuters
·
Apr 29

Fennec Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 29